Healthcare
RSV vaccine to be 37% subsidized for the population over 60
The government will implement a 37% subsidy for the Respiratory Syncytial Virus (RSV) vaccine for people over 60 by the end of October 2026. This reduces the retail price from approximately 190 euros to 120 euros.
Why it mattersIf you are 60 or older, you will be able to purchase the RSV vaccine at a lower cost of 120 euros starting by the end of this month, helping to protect against lower respiratory tract infections.
Correio da ManhãRead original ↗
